stars 1 stars 2 stars 3

The Dipharma Group is a global CDMO and one of the leading family-owned manufacturers of Active Pharmaceutical Ingredients and Intermediates, having a portfolio of more than 40 products, with Drug Master Files lodged worldwide. Dipharma serves top ranking pharmaceutical companies in Europe, U.S.A. and Japan. Supported by a fully equipped R&D Centers, its core technologies are Nitration, Nitroesterification, Azide Chemistry, High Pressure Hydrogenation, Chiral Synthesis, Organometallic Chemistry and Enzymatic Processes.

Dipharma Francis S.r.l Questions

The Dipharma Francis S.r.l annual revenue was $43.7 million in 2026.

Chiara Mauri is the CFO of Dipharma Francis S.r.l.

242 people are employed at Dipharma Francis S.r.l.

The NAICS codes for Dipharma Francis S.r.l are [325, 32, 3254, 32541].

The SIC codes for Dipharma Francis S.r.l are [283, 28].

Top Dipharma Francis S.r.l Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users